Al-Modawat Specialized Medical (9594) Fundamentals 2026 — P/E 4.1x, Revenue Analysis | SniperIQ
Al-Modawat Specialized Medical (9594) is a SA-listed Healthcare company in Medical - Care Facilities with a market capitalization of SAR 110M, trading at SAR 4.77 on the SAU. This SniperIQ fundamentals page covers Al-Modawat Specialized Medical's valuation (P/E 4.1x, P/B 0.7x), profitability (net margin 15.6%), revenue (SAR 122M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Al-Modawat Specialized Medical's market cap?
Al-Modawat Specialized Medical (9594) has a market capitalization of approximately SAR 110M, trading at SAR 4.77 on the SAU. Market cap moves with the live share price.
What is Al-Modawat Specialized Medical's P/E ratio?
Al-Modawat Specialized Medical's trailing twelve-month P/E ratio is 4.1x, with a price-to-book (P/B) of 0.7x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Al-Modawat Specialized Medical?
Al-Modawat Specialized Medical runs a net profit margin of 15.6%, a gross margin of 43.5%, and an operating margin of 18.1%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Al-Modawat Specialized Medical generate?
Al-Modawat Specialized Medical reported revenue of SAR 122M for fiscal year 2025, with net income of SAR 19M and earnings per share (EPS) of 0.27. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Al-Modawat Specialized Medical pay a dividend?
Al-Modawat Specialized Medical offers a trailing dividend yield of about 2.5%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Al-Modawat Specialized Medical financially healthy?
Al-Modawat Specialized Medical carries a debt-to-equity ratio of 0.19x and a current ratio of 1.52x, with a market beta of 0.83. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Al-Modawat Specialized Medical a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Al-Modawat Specialized Medical (9594) the key facts are: market cap SAR 110M, P/E 4.1x, revenue SAR 122M, 52-week range 3.06-6.56. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Al-Modawat Specialized Medical's full fundamentals live
Get Al-Modawat Specialized Medical's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.